Photocure (Norway) Management Evaluation
| PHO Stock | NOK 55.40 1.00 1.84% |
Photocure employs about 97 people. The company is managed by 27 executives with a total tenure of roughly 172 years, averaging almost 6.0 years of service per executive, having 3.59 employees per reported executive. Inspection of Photocure's management performance can provide insight into the company performance.
| Kjetil Hestdal CEO President CEO |
| Daniel Schneider CEO President CEO |
Photocure |
Photocure Management Team Effectiveness
The company has return on total asset (ROA) of (0.0309) % which means that it has lost $0.0309 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1567) %, meaning that it generated substantial loss on money invested by shareholders. Photocure's management efficiency ratios could be used to measure how well Photocure manages its routine affairs as well as how well it operates its assets and liabilities.Photocure Workforce Comparison
Photocure is considered to be number one stock in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 82,849. Photocure adds roughly 97.0 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (0.2) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.1. Photocure Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Photocure Price Series Summation is a cross summation of Photocure price series and its benchmark/peer.
Photocure Notable Stakeholders
A Photocure stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Photocure often face trade-offs trying to please all of them. Photocure's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Photocure's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kjetil Hestdal | President CEO | Profile | |
| Daniel Schneider | President CEO | Profile | |
| Jan Egberts | Chairman of the Board | Profile | |
| BenteLill Romoren | Chairman of the Board | Profile | |
| Grete Hogstad | Vice President of Strategic Marketing | Profile | |
| Inger Heglund | Vice President of Research and Development | Profile | |
| Kathleen Deardorff | COO | Profile | |
| Einar Antonsen | Director | Profile | |
| Tove Ringvold | Director | Profile | |
| Synne Roine | Director | Profile | |
| Xavier Yon | Director | Profile | |
| Johanna Holldack | Director | Profile | |
| Gwen Mellincoff | Director | Profile | |
| Lars Ronn | Director | Profile | |
| Grannum Sant | Director | Profile | |
| Tom Pike | Director | Profile | |
| Gry Stensrud | VP of Technical Devel. and Operations | Profile | |
| Tolv Hillestad | Group Controller | Profile | |
| Patricia Kelly | VP HR | Profile | |
| Jeremy Bahr | Chief Business Officer | Profile | |
| David Moskowitz | Head Relations | Profile | |
| Anders Neijber | Clinical Affairs | Profile | |
| Geoffrey Coy | VP Operations | Profile | |
| Erik Dahl | Chief Officer | Profile | |
| Kari MD | Head Devel | Profile | |
| Ambaw Bellete | Head of United States Cancer Commercial Operations | Profile | |
| Espen Njastein | Head of Nordic Cancer Commercial Operations | Profile |
About Photocure Management Performance
The success or failure of an entity such as Photocure often depends on how effective the management is. Photocure management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Photocure management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Photocure management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment in Nordic countries and the United States. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. PHOTOCURE ASA operates under Drug Manufacturers - Major classification in Norway and is traded on Oslo Stock Exchange. It employs 71 people.
The data published in Photocure's official financial statements usually reflect Photocure's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Photocure. For example, before you start analyzing numbers published by Photocure accountants, it's critical to develop an understanding of what Photocure's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Photocure's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Photocure's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Photocure's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Photocure. Please utilize our Beneish M Score to check the likelihood of Photocure's management manipulating its earnings.
Photocure Workforce Analysis
Traditionally, organizations such as Photocure use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Photocure within its industry.Photocure Manpower Efficiency
Return on Photocure Manpower
| Revenue Per Employee | 3.7M | |
| Revenue Per Executive | 13.4M | |
| Net Loss Per Employee | 318.5K | |
| Net Loss Per Executive | 1.1M | |
| Working Capital Per Employee | 1.7M | |
| Working Capital Per Executive | 6M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Photocure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Photocure Stock analysis
When running Photocure's price analysis, check to measure Photocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Photocure is operating at the current time. Most of Photocure's value examination focuses on studying past and present price action to predict the probability of Photocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Photocure's price. Additionally, you may evaluate how the addition of Photocure to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |